Novacyt S.A. ("Novacyt", the "Company" or the “Group”): Half Year 2020 Results

Credit: Business Wire- Published 3 days ago
PARIS & CAMBERLEY, England--(BUSINESS WIRE)--Regulatory News: Novacyt (ALTERNEXT: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces its unaudited results for the six months ended 30 June 2020 and provides an update on its growth strategy. Summary highlights H1 2020 sales of €72.4 million and EBITDA of €49.4 million, resulting from the sale of the Company’s market leading PCR COVID-19 test, has transformed Novacyt Performance provides period end cash of €19.7m, fo
Advertisement

You are here

Related news from verified sources

Paris, 18^th September 2020 *Postponement of the publication of the half year results until 30^th September 2020* *Marie Brizard Wine and Spirits (Euronext...
2 days ago • GlobeNewswire

Paris, 16 September 2020, 5.45pm *HALF YEAR RESULTS:**TURNOVER €1 BILLION* *CONSOLIDATED NET PROFIT €10 MILLION* The Executive Board of SYNERGIE,...
3 days ago • GlobeNewswire

CLERMONT-FERRAND, France--(BUSINESS WIRE)--2020 Half-Year Results for CARBIOS, the world leader in biorecycling and biodegrading plastics
3 days ago • Business Wire

You might like